OVERVIEW
Artificial Intelligence (AI) is rapidly changing Medicine, especially oncology: it offers groundbreaking tools to optimize clinical trial design, improve patient selection, accelerate fact collection from real-world data, increase clinical experimentation in efficiency, and maximize of innovative pharmacological treatments, e. g. immunotherapy and targeted therapy.
The event promises to explore AI potential in oncological clinical research with a multidisciplinary and clinical-praxis-oriented approach.
THE FOLLOWING SPECIFIC OBJECTIVES WILL BE DISCUSSED:
Innovative clinical trial design
New experimental models will be explained, including adaptive studies,“umbrella” and “basket trials, as well as the use of synthetic arms and RWD (real-world data) data, to make studies more agile, efficient and less costly.
Clinical Trial Matching boosted by IA
AI can automatically select patients eligible for studies.Therefore, AI can enhance equity in accessing and efficiency in recruiting, even in complex, personalized trials.
AI-driven biomarkers and validation
The integration of AI-based predictive biomarkers derived from genomic, clinical, and radiomic data will be discussed, focusing on the level of validation required for their adoption in regulatory and clinical settings.
Ethics, biases, and legal framework in AI
A proper use of AI requires great attention to algorithmic biases, discrepancies in its access and ethical responsibilities.
European regulatory principles and implications for AI-assisted trials will be presented.
From validation to clinical implementation
Lastly, strategies to efficiently validate and integrate AI models in therapeutic planning and in everyday oncological praxis will be examined.
Registration is free of charge. You may register for IN-PERSON OR ONLINE-ONLY ACCESS
ADDITIONAL INFORMATION FOR COMPANIES’ REGISTRATION FEE
If you work for a profit company (not sponsoring the event), you must pay a registration fee: Euro 100.00 including VAT and taxes. Please contact directly segreteria3@events-communication.com
